Hazard identification and risk assessment for biologics targeting the immune system [0.03%]
针对免疫系统的生物制品的危害识别和风险评估
Andrea B Weir
Andrea B Weir
Biologic pharmaceuticals include a variety of products, such as monoclonal antibodies, fusion proteins and cytokines. Products in those classes include immunomodulatory biologics, which are intended to enhance or diminish the activity of th...